ENTX
Entera Bio Ltd
NASDAQ: ENTX · HEALTHCARE · BIOTECHNOLOGY
$1.19
+6.25% today
Updated 2026-04-30
Market cap
$60.98M
P/E ratio
—
P/S ratio
1,452.00x
EPS (TTM)
$-0.25
Dividend yield
—
52W range
$1 – $3
Volume
0.2M
Entera Bio Ltd (ENTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-27,450.00%
ROE
-108.00%
ROA
-56.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | $0.00 | $-4.28M | — | — | — |
| 2016 | $0.00 | $-1.20M | — | — | — |
| 2017 | $0.00 | $-11.20M | — | — | — |
| 2018 | $500000.00 | $-10.30M | 100.00% | -2,172.20% | -2,060.80% |
| 2019 | $236000.00 | $-10.79M | -89.83% | -4,853.39% | -4,574.15% |
| 2020 | $365000.00 | $-9.98M | 42.74% | -3,050.14% | -2,735.07% |
| 2021 | $571000.00 | $-12.19M | 34.68% | -2,139.58% | -2,134.33% |
| 2022 | $134000.00 | $-13.07M | 24.63% | -9,714.18% | -9,754.48% |
| 2023 | $14000.00 | $-8.89M | -400.00% | -63,857.14% | -63,492.86% |
| 2024 | $181000.00 | $-9.54M | 4.97% | -5,295.58% | -5,271.27% |
| 2025 | $42000.00 | $-11.44M | -71.43% | -27,450.00% | -27,235.71% |